News & Events
-
May 4, 2023
Results of the 2022 global WHO online survey on diagnostic capacities and treatment practices for implantation (deep) mycoses
Barbara Milani (WHO consultant), under the guidance of Daniel Argaw Dagne (WHO Department of Control of Neglected Tropical Diseases [WHO/NTD]), Heather Stone (United States Food and Drug Administration [USFDA], Marco Schito (CURE Drug Repurposing Collaboratory),David Denning (Global Action Fund for Fungal Infections, Geneva, Switzerland), Roderick Hay (International Foundation for Dermatology, London, United Kingdom of Great...... -
May 4, 2023
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools
Heavner, Smith F. PhD, RN1,2; Anderson, Wesley PhD3; Kashyap, Rahul MBBS, MBA4,5; Dasher, Pamela BA1; Mathé, Ewy A. PhD6; Merson, Laura7; Guerin, Philippe J. MD, PhD8,9; Weaver, Jeff MBA10; Robinson, Matthew MD11; Schito, Marco PhD1; Kumar, Vishakha K. MD, MBA12; Nagy, Paul PhD13 COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near...... -
March 16, 2023
Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature
According to the latest guidelines by the Infectious Disease Society of America (IDSA), there is no defined standard of care for Acinetobacter baumannii infections, especially the ones with carbapenem resistant phenotypes. The IDSA guidelines do not comment on the utility of cefoperazone sulbactam since this an old drug that is no longer available in the...... - February 16, 2023
- September 21, 2022